Vaccine Testing: Asia Sees The West As A Guinea Pig

Vaccine Testing: Asia Sees The West As A Guinea Pig
Vaccine Testing: Asia Sees The West As A Guinea Pig

Video: Vaccine Testing: Asia Sees The West As A Guinea Pig

Отличия серверных жестких дисков от десктопных
Video: Coronavirus vaccine trials in Africa: What you need to know - BBC Africa 2023, February

Regions of the world have diverged in approaches to the problem of vaccination of the population against the new coronavirus. Experts note that Asia, unlike the countries of the conditional West, is in no hurry with mass vaccinations in order to see how already developed drugs will affect the life of Europe and the United States. There is reason to believe that this approach will lead to uneven economic recovery after quarantine restrictions.

The Financial Times writes that regulators in Asian countries are considering Westerners as the first guinea pigs for already approved vaccines. According to the British newspaper, the caution of the macro-region, which in the first months of the pandemic became the leader in the spread of the new coronavirus, is in contrast to the American and European approaches to vaccination policy, which boil down to the principle of "the sooner the better." Thus, the publication cites the opinion of South Korean health experts who believe that large-scale vaccinations in the country are unlikely until the fall of 2021, because any drug must pass a safety check. Australia and Vietnam are in a similar position, with their regulators calling for more data on vaccine safety. As for Japan, it can begin large-scale vaccinations, according to the Financial Times, only in 2022.

As for the Chinese specialists, they have developed a number of vaccines. Some are approved for temporary emergency use. By and large, drugs from the PRC were among the first on which clinical trials began, but the process slowed down in the final stages. Maybe that's why observers have noted problems with large-scale vaccine trials. Instead of testing the effectiveness of their drugs at the national level, Chinese developers have entered into agreements to conduct trials in more than ten countries, including Brazil, Indonesia, Pakistan and Russia. In return, a commitment was made to provide early access to vaccines as soon as they are ready.

The wait-and-see attitude can have its consequences. The authorities of those countries where there is a slow progress in the issue of vaccination, the risk to face the dissatisfaction of their own citizens, who may want to be vaccinated as soon as possible in order to return to normal life.

Officially, in the countries of the world, a variety of vaccination dates are called: end of December, beginning, spring or mid 2021. There is an international mechanism for accessing COVAX vaccines, under which 2 billion doses of vaccine against the new coronavirus are to be created and evenly distributed around the world by the end of 2021. Most countries intend to vaccinate on a free and voluntary basis.

Last week, the Director-General of the World Health Organization (WHO) Tedros Adanom Ghebreyesus called on international donors to urgently provide $ 4.3 billion to ensure access to drugs for "countries in need". This is the sum of the shortfall that arose from the vaccine procurement program. The problem, according to the director-general of WHO, must be resolved as quickly as possible to be able to reserve drugs, "save lives and accelerate a true recovery of the global economy."

However, the latter is not yet to be expected. Problems in the future can be created, including the very difference in approaches to vaccination, experts say.Not to mention the fact that this issue determines how much transport links between countries are able to return to the previous dynamics.

Popular by topic